EULAR Abstract Awards

EULAR bestows Abstract Awards to the first authors of abstracts submitted to the EULAR Annual European Congress. Winners are selected by the EULAR Scientific Programme Committee based on the quality of the abstracts' scientific content. The award ceremony takes place at the EULAR Annual European Congress' Opening plenary session.

 

Winners of EULAR Awards 2020

 

Basic science

  • Dr. Gwenny M. Verstappen, Netherlands
    The transcriptome of paired minor and major salivary gland tissue in patients with primary Sjögren's syndrome: two of a kind?
    Abstract archive
    Presentation at the EULAR 2020 E-Congress

  • PhD Christopher Lessard, United States
    Genome-wide association study of Sjögren’s syndrome identifies ten new risk loci
    Abstract archive
    Presentation at the EULAR 2020 E-Congress

  • Dr. Simon Mastbergen, Netherlands
    Dorsal Root Ganglia Infiltrating Macrophages maintain Osteoarthritis Pain
    Abstract archive
    Presentation at the EULAR 2020 E-Congress

  • Dr. Yubin Luo, China
    Gut microbiota dysbiosis in the high-risk individual for RA triggers the mucosal immunity perturbation and promotes rheumatoid arthritis development
    Abstract archive

  • Prof. Chamutal Gur, Israel
    Single cell profile of skin stromal and immune cells and peripheral blood immune cells of scleroderma patients towards identification of disease mechanism, prognostic biomarkers and potential therapeutic targets
    Abstract archive

 

Clinical

  • Dr. Martin Schaefer, Germany
    TNF inhibitors are associated with a reduced risk of venous thromboembolism compared to csDMARDs in RA patients.
    Abstract archive
     
  • Dr. Anna Moltó, France
    Cluster-randomized pragmatic clinical trial evaluating the potential benefit of a tight-control and treat-to-target strategy in axial Spondyloarthritis: the results of the TICOSPA trial
    Abstract archive
    Presentation at the EULAR 2020 E-Congress

  • MD, PhD Ulf Lindström, Sweden
    Comparison of anterior uveitis occurrence during treatment with secukinumab, adalimumab, infliximab and etanercept in spondyloarthritis
    Abstract archive

  • MD Andre Luquini, Canada
    Effectiveness of the Making it Work™ Program at Improving Presenteeism and Work Cessation in Workers with Inflammatory Arthritis – Results of a Randomized Controlled Trial
    Abstract archive

  • Dr. Sebastian Unizony, United States
    Mass Spectrometry Identifies Novel Biomarkers in Giant Cell Arteritis, Useful in Patients on Interleukin-6 Receptor Blockade
    Abstract archive
     
  • Dr. Rona Smith, United Kingdom
    A randomized, controlled trial of rituximab versus azathioprine after induction of remission with rituximab for patients with ANCA-associated vasculitis and relapsing disease
    Abstract archive
    Presentation at the EULAR 2020 E-Congress


PARE (People with Arthritis / Rheumatism in Europe)


Undergraduate

 

HPR (Health Professionals in Rheumatology)

 

FOREUM